GENE
Genetic Technologies Ltd.
GENE
GENE
Delisted
GENE was delisted on the 16th of October, 2024.
13 hedge funds and large institutions have $413K invested in Genetic Technologies Ltd. in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
44% less capital invested
Capital invested by funds: $735K → $413K (-$322K)
Holders
13
Holding in Top 10
–
Calls
$463K
Puts
$208K
Top Buyers
| 1 | +$75.6K | |
| 2 | +$51.2K | |
| 3 | +$28K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$25.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$11.8K |
Top Sellers
| 1 | -$131K | |
| 2 | -$41K | |
| 3 | -$34K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$21K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$11.3K |